Ramsay Générale de Santé SA (GDS.PA)
- Previous Close
10.85 - Open
10.80 - Bid --
- Ask --
- Day's Range
10.75 - 10.85 - 52 Week Range
9.46 - 16.75 - Volume
763 - Avg. Volume
974 - Market Cap (intraday)
1.186B - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
-- - EPS (TTM)
-0.72 - Earnings Date Aug 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 2, 2014
- 1y Target Est
--
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. The company operates proximity care centers, and clinics and specialized hospitals; and provides primary medicine, medicine surgery obstetrics (MSO) dialysis, oncology, medical imaging, medical care, follow-up and rehabilitation care, home care and hospitalization, mental health care, and addiction treatment, telemedicine e health, elderly, emergency, maternity, nutrition, obesity and eating disorders, sanitary transport, outpatient surgery and eras, and SMR services. Ramsay Générale de Santé SA was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. The company was founded in 1987 and is headquartered in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
www.ramsaygds.fr34,218
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: GDS.PA
View MorePerformance Overview: GDS.PA
Trailing total returns as of 6/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GDS.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GDS.PA
View MoreValuation Measures
Market Cap
1.20B
Enterprise Value
4.79B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.24
Price/Book (mrq)
--
Enterprise Value/Revenue
0.93
Enterprise Value/EBITDA
8.28
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.55%
Return on Assets (ttm)
1.48%
Return on Equity (ttm)
-5.16%
Revenue (ttm)
5.14B
Net Income Avi to Common (ttm)
-79.7M
Diluted EPS (ttm)
-0.72
Balance Sheet and Cash Flow
Total Cash (mrq)
157.8M
Total Debt/Equity (mrq)
337.92%
Levered Free Cash Flow (ttm)
287.14M